Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 022067
Company: TARO
Company: TARO
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
FLO-PRED | PREDNISOLONE ACETATE | EQ 5MG BASE/5ML | SUSPENSION;ORAL | Discontinued | None | No | No |
FLO-PRED | PREDNISOLONE ACETATE | EQ 15MG BASE/5ML | SUSPENSION;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/17/2008 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022067lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022067s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022067_flo-pred_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022067s000sumr.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
07/15/2021 | SUPPL-14 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022067s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/022067Orig1s014ltr.pdf | |
10/03/2014 | SUPPL-12 | Manufacturing (CMC) |
Label is not available on this site. |
||
09/29/2014 | SUPPL-11 | Manufacturing (CMC) |
Label is not available on this site. |
||
02/28/2014 | SUPPL-10 | Manufacturing (CMC) |
Label is not available on this site. |
||
06/14/2011 | SUPPL-7 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022067s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022067s007ltr.pdf | |
05/06/2010 | SUPPL-4 | Manufacturing (CMC) |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022067s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022067s004ltr.pdf | |
10/03/2008 | SUPPL-2 | Labeling-Container/Carton Labels, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022067s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022067s002ltr.pdf | |
06/27/2008 | SUPPL-1 | Labeling-Container/Carton Labels, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022067s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022067s001ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
07/15/2021 | SUPPL-14 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022067s014lbl.pdf | |
06/14/2011 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022067s007lbl.pdf | |
05/06/2010 | SUPPL-4 | Manufacturing (CMC) | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022067s004lbl.pdf |
10/03/2008 | SUPPL-2 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022067s002lbl.pdf | |
10/03/2008 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022067s002lbl.pdf | |
06/27/2008 | SUPPL-1 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022067s001lbl.pdf | |
06/27/2008 | SUPPL-1 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022067s001lbl.pdf | |
01/17/2008 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022067lbl.pdf |